UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 65

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk

The journal of clinical endocrinology and metabolism, 2004-06, Vol.89 (6), p.2601-2607

2004

Volltextzugriff (PDF)

Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1104-1110

2009

Volltextzugriff (PDF)

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies

Endocrine reviews, 2006-10, Vol.27 (6), p.575-605

2006

Volltextzugriff (PDF)

The Emergence of the Metabolic Syndrome with Menopause

The journal of clinical endocrinology and metabolism, 2003-06, Vol.88 (6), p.2404-2411

Carr, Molly C

2003

Volltextzugriff (PDF)

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

Diabetes care, 2020-10, Vol.43 (10), p.2509-2518

2020

Volltextzugriff (PDF)

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

Journal of lipid research, 2003-07, Vol.44 (7), p.1279-1286

2003

Volltextzugriff (PDF)

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea

Diabetologia, 2014-12, Vol.57 (12), p.2475-2484

2014

Volltextzugriff (PDF)

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

The Lancet (British edition), 2024-09, Vol.404 (10458), p.1132-1142

2024

Volltextzugriff (PDF)

Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study

Diabetes care, 2014-10, Vol.37 (10), p.2723-2730

2014

Volltextzugriff (PDF)

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment

The New England journal of medicine, 2024-09

2024

Volltextzugriff (PDF)

Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study

Journal of diabetes investigation, 2018-05, Vol.9 (3), p.558-566

2018

Volltextzugriff (PDF)

Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme

Diabetes, obesity & metabolism, 2024-08, Vol.26 (8), p.3020-3030

2024

Volltextzugriff (PDF)

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

British journal of pharmacology, 2023-08, Vol.180 (15), p.1965-1980

2023

Volltextzugriff (PDF)

Albiglutide for the treatment of type 2 diabetes mellitus: an integrated safety analysis of the HARMONY phase 3 trials

Diabetes research and clinical practice, 2017-04, Vol.126, p.230-239

2017

Volltextzugriff (PDF)

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: long-term efficacy with or without rescue therapy

Diabetes research and clinical practice, 2017-09, Vol.131, p.49-60

2017

Volltextzugriff (PDF)

Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs

Current medical research and opinion, 2017-03, Vol.33 (3), p.431-438

2017

Volltextzugriff (PDF)

Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy

Diabetes care, 2005-07, Vol.28 (7), p.1555-1561

2005

Volltextzugriff (PDF)

Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes

Postgraduate medicine, 2016-05, Vol.128 (4), p.391-397

2016

Volltextzugriff (PDF)

PLTP activity in premenopausal women: relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance

Journal of lipid research, 2000-02, Vol.41 (2), p.237-244

2000

Volltextzugriff (PDF)

Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement

Journal of lipid research, 2002-02, Vol.43 (2), p.281-289

2002

Volltextzugriff (PDF)

Increased urinary cortisol levels during the menopausal transition

Menopause (New York, N.Y.), 2006-03, Vol.13 (2), p.212

2006

Volltextzugriff (PDF)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution

Journal of lipid research, 2002-08, Vol.43 (8), p.1256-1263

2002

Volltextzugriff (PDF)

Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia

Annals of internal medicine, 2003-12, Vol.139 (12), p.996

2003

Volltextzugriff (PDF)

The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity

The journal of clinical endocrinology and metabolism, 2001-06, Vol.86 (6), p.2831-2837

2001

Volltextzugriff (PDF)

The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity1

The journal of clinical endocrinology and metabolism, 2001-06, Vol.86 (6), p.2831-2837

2001

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(64)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(48)
Humans
(38)
Female
(26)
Male
(18)
Middle Aged
(15)
Adult
(14)
Endocrinology & Metabolism
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(10)
Aged
(9)
Biochemistry & Molecular Biology
(9)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Diabetes
(7)
Diabetes Mellitus
(7)
Diabetes Mellitus, Type 2 - Drug Therapy
(7)
Glucagon-Like Peptide 1 - Analogs & Derivatives
(7)
Medicine
(7)
Animals
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk

Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies

The Emergence of the Metabolic Syndrome with Menopause

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment

Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study

Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme

Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure

Albiglutide for the treatment of type 2 diabetes mellitus: an integrated safety analysis of the HARMONY phase 3 trials

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: long-term efficacy with or without rescue therapy

Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs

Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy

Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes

PLTP activity in premenopausal women: relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance

Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement

Increased urinary cortisol levels during the menopausal transition

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution

Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia

The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity

The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity1

Suchergebnisse filtern